Literature DB >> 17628876

Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.

Simone I Hoehle1, Erika Pfeiffer, Manfred Metzler.   

Abstract

Glucuronidation is an important pathway in the metabolism of curcumin, but the isoforms of uridine-5'-diphosphoglucuronosyltransferase (UGT) involved are not known. Here, we report on the glucuronidation of the three natural curcuminoids and their major phase I metabolites with microsomes from human liver and intestine as well as with human recombinant UGTs. Microsomes from human liver generated predominantly the phenolic and small amounts of the alcoholic glucuronide of each curcuminoid, whereas intestinal microsomes formed only the phenolic conjugates but with higher activities. The phenolic glucuronidation of the curcuminoids was predominantly catalyzed by hepatic UGT1A1 and intestinal UGT1A8 and 1A10, whereas UGT1A9, 2B7, and 1A8 exhibited high activities for hexahydro-curcuminoids. UGT1A9 was able to form the alcoholic glucuronide of each curcuminoid in addition to the phenolic conjugate. These data suggest that the gastrointestinal tract contributes substantially to the glucuronidation of curcuminoids in humans, which may have important implications for their pharmacokinetic fate in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628876     DOI: 10.1002/mnfr.200600283

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  24 in total

1.  Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.

Authors:  Liu Zhongfa; Ming Chiu; Jiang Wang; Wei Chen; Winston Yen; Patty Fan-Havard; Lisa D Yee; Kenneth K Chan
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

2.  Pharmacokinetics and pharmacodynamics of three oral formulations of curcumin in rats.

Authors:  Lujing Wang; Wenji Li; David Cheng; Yue Guo; Renyi Wu; Ran Yin; Shanyi Li; Hsiao-Chen Kuo; Rasika Hudlikar; Hilly Yang; Brian Buckley; Ah-Ng Kong
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-04       Impact factor: 2.745

3.  Oxidative metabolism of curcumin-glucuronide by peroxidases and isolated human leukocytes.

Authors:  Paula B Luis; Odaine N Gordon; Fumie Nakashima; Akil I Joseph; Takahiro Shibata; Koji Uchida; Claus Schneider
Journal:  Biochem Pharmacol       Date:  2017-03-06       Impact factor: 5.858

4.  In vitro glucuronidation of 2,2-bis(bromomethyl)-1,3-propanediol by microsomes and hepatocytes from rats and humans.

Authors:  Golriz Rad; Simone I Hoehle; Robert K Kuester; I Glenn Sipes
Journal:  Drug Metab Dispos       Date:  2010-03-03       Impact factor: 3.922

5.  Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin.

Authors:  Alex E Grill; Brenda Koniar; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

6.  Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells.

Authors:  Otito F Iwuchukwu; Ronald J Tallarida; Swati Nagar
Journal:  Life Sci       Date:  2011-04-03       Impact factor: 5.037

Review 7.  Metabolism as a key to histone deacetylase inhibition.

Authors:  Praveen Rajendran; David E Williams; Emily Ho; Roderick H Dashwood
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-04-05       Impact factor: 8.250

8.  Intravenous Curcumin Mitigates Atherosclerosis Progression in Cholesterol-Fed Rabbits.

Authors:  Amir Abbas Momtazi-Borojeni; Narges Amel Zabihi; Ramin Khameneh Bagheri; Muhammed Majeed; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.

Authors:  Peng Zou; Lawrence Helson; Anirban Maitra; Stephan T Stern; Scott E McNeil
Journal:  Mol Pharm       Date:  2013-04-22       Impact factor: 4.939

10.  Glucuronidation of the mycotoxins alternariol and alternariol-9-methyl ether in vitro: chemical structures of glucuronides and activities of human UDP-glucuronosyltransferase isoforms.

Authors:  E Pfeiffer; C Schmit; B Burkhardt; M Altemöller; J Podlech; M Metzler
Journal:  Mycotoxin Res       Date:  2008-12-23       Impact factor: 3.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.